Praxis Precision Medicines to Showcase Updates From Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting
Praxis Solutions Welcomes Andre Hatibi as Senior Vice President of Business Development
Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $270
Piper Sandler Gives a Buy Rating to Praxis Precision Medicines (PRAX)
A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $114 to $120
Praxis Precision Medicines Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags